Stocks to Watch into the Close & After-Hours: New Highs, Squeeze Alerts & More

July 18, 2025

DENVER, Colo., Jul 18, 2025 (247marketnews.com)- Today’s trading session has set the stage for potential after-hours moves, with several names surging toward or hitting fresh 52-week highs.

Shares of Venu (NYSE:VENU) are on watch with several sexy catalysts converging, after the company retained Texas Capital Securities to arrange $200 million in non-dilutive private debt commitments, aimed at expanding its amphitheater network. The move follows a Strong Buy rating and $22.30 price target from Cenorium.

With 8+ days to cover, VENU is now on the radar as a high-probability short squeeze candidate into after-hours. Watch for volume spikes and continuation above recent highs.

Opendoor (NASDAQ:OPEN) has been trending upward with strength, and if momentum holds, it could break into new 52-week high territory. Real estate tech remains one of the more resilient themes this earnings season.

Siyata (NASDAQ:SYTA) is nearing completion of its $185 million merger with Core Gaming, pending Nasdaq approval, an AI-powered entertainment platform with 43 million monthly active users. The combined company will be led by Core Gaming CEO Aitan Zacharin, with legacy Siyata shareholders retaining 10% equity. With a $100 million revenue target for 2025, this could be a transformative pivot for SYTA from rugged communications hardware to AI-driven media and gaming.

New 52-Week Highs & Strong Bullish Setups

EV battery innovator Solid Power (NASDAQ:SLDP) hit a fresh 52-week high of $3.86 today. With energy storage back in focus, this could be a breakout to watch.

AbCellera Biologics (NASDAQ:ABCL) shares broke out to a 52-week high of $4.70, riding on renewed biotech momentum and strong institutional buying.

CRISPR Therapeutics AG (NASDAQ:CRSP)
CRSP soared to a new 52-week high of $66.49, driven by sector-wide optimism in gene editing and a potential rebound in risk-on biotech names.

Fresh breakout alert: ATAI Life Sciences (NASDAQ:ATAI) pushed to a new high of $3.35, following positive sentiment around psychedelic-assisted mental health therapies. Speculative momentum is in play.

Invesco (NYSE:IVZ) quietly set a 52-week high at $19.87, buoyed by strong fund inflows and stability in the asset management sector.

After announcing a $120 million hybrid AI deployment deal in Asia, Blaize (NASDAQ:BZAI) has held above the key $5 level, keeping its bullish trend intact. As long as $5 holds, traders see room for continued strength.

Cyclacel Pharmaceuticals (NASDAQ:CYCC) made a huge move Tuesday on no news, raising eyebrows. Keep this on the radar for a potential catalyst-driven follow-up in extended hours.

Rebound Setup

BitMine Immersion Technologies Inc. (NYSE:BMNR) is well off its recent highs, but has held a consolidation range that’s attracting dip buyers. With crypto exposure in focus this week (thanks to MEI Pharma and GameSquare news), BMNR could be a low-float rebound play.

AgEagle (NYSE:UAVS) has been on a multiweek rally, driven by speculative drone-sector interest. Keep an eye on volume—momentum traders are watching for a breakout continuation.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For additional 247marketnews.com Siyata disclosure https://247marketnews.com/syta-siyata-mobile-update/ or https://247marketnews.com/venu-disclosure/ for additional VENU disclosure.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, SYTA, OPEN, SLDP, ABCL, CRSP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.